Johnson & Johnson
(JNJ)
|
8.2 |
$108M |
|
654k |
164.35 |
Eli Lilly & Co.
(LLY)
|
6.1 |
$80M |
|
429k |
186.82 |
Abbvie
(ABBV)
|
5.0 |
$65M |
|
600k |
108.22 |
Merck & Co
(MRK)
|
4.8 |
$62M |
|
809k |
77.09 |
Sanofi Sponsored Adr
(SNY)
|
3.8 |
$49M |
|
998k |
49.46 |
Astrazeneca Sponsored Adr
(AZN)
|
3.7 |
$48M |
|
961k |
49.72 |
Ishares Tr Put Put Option
(IWM)
|
3.6 |
$46M |
|
210k |
220.94 |
Enphase Energy Call Call Option
(ENPH)
|
2.9 |
$37M |
|
230k |
162.16 |
Generac Holdings
(GNRC)
|
2.7 |
$35M |
|
106k |
327.45 |
Ishares Tr Put Put Option
(IGV)
|
1.9 |
$24M |
|
71k |
341.42 |
Fiverr Intl Call Call Option
(FVRR)
|
1.7 |
$22M |
|
100k |
217.18 |
Kura Oncology
(KURA)
|
1.6 |
$20M |
|
718k |
28.27 |
Teva Pharmaceutical Inds Sponsored Ads
(TEVA)
|
1.5 |
$20M |
|
1.7M |
11.54 |
C4 Therapeutics Com Stk
(CCCC)
|
1.4 |
$18M |
|
497k |
36.99 |
Mohawk Group Holdings Ord
|
1.4 |
$18M |
|
607k |
29.50 |
Microsoft Corporation
(MSFT)
|
1.2 |
$16M |
|
68k |
235.77 |
Kornit Digital SHS
(KRNT)
|
1.1 |
$15M |
|
148k |
99.12 |
Syndax Pharmaceuticals
(SNDX)
|
1.1 |
$14M |
|
638k |
22.36 |
LivePerson
(LPSN)
|
1.1 |
$14M |
|
260k |
52.74 |
Essa Pharma Com New
(EPIX)
|
1.0 |
$14M |
|
469k |
29.05 |
Audiocodes Ord
(AUDC)
|
1.0 |
$13M |
|
476k |
26.98 |
Bristol Myers Squibb
(BMY)
|
1.0 |
$13M |
|
200k |
63.13 |
Oncorus
|
1.0 |
$13M |
|
903k |
13.92 |
Cerevel Therapeutics Hldng I
(CERE)
|
1.0 |
$13M |
|
912k |
13.73 |
Palo Alto Networks
(PANW)
|
0.8 |
$10M |
|
32k |
322.07 |
Ishares Tr Put Put Option
(ICLN)
|
0.8 |
$10M |
|
420k |
24.30 |
Springworks Therapeutics
(SWTX)
|
0.8 |
$10M |
|
138k |
73.57 |
Curis Com New
|
0.8 |
$10M |
|
886k |
11.32 |
Orchard Therapeutics Ads
|
0.8 |
$9.9M |
|
1.4M |
7.26 |
Kymera Therapeutics
(KYMR)
|
0.7 |
$9.6M |
|
248k |
38.86 |
Alx Oncology Hldgs
(ALXO)
|
0.7 |
$9.6M |
|
130k |
73.74 |
Fate Therapeutics
(FATE)
|
0.7 |
$9.1M |
|
110k |
82.45 |
Vistagen Therapeutics Com New
|
0.7 |
$8.9M |
|
4.2M |
2.13 |
Zai Lab Adr
(ZLAB)
|
0.7 |
$8.8M |
|
66k |
133.43 |
Nice Sponsored Adr
(NICE)
|
0.7 |
$8.6M |
|
40k |
217.98 |
Amazon
(AMZN)
|
0.7 |
$8.5M |
|
2.8k |
3094.17 |
Perrigo Call Call Option
(PRGO)
|
0.7 |
$8.5M |
|
210k |
40.47 |
Onto Innovation
(ONTO)
|
0.6 |
$8.2M |
|
125k |
65.71 |
Ishares Tr Put Put Option
(TLT)
|
0.6 |
$8.1M |
|
60k |
135.45 |
Sigilon Therapeutics
|
0.6 |
$8.1M |
|
362k |
22.28 |
Affimed Therapeutics B V
|
0.6 |
$8.1M |
|
1.0M |
7.91 |
Bolt Biotherapeutics
(BOLT)
|
0.6 |
$7.9M |
|
241k |
32.91 |
Repare Therapeutics Ord
(RPTX)
|
0.6 |
$7.6M |
|
248k |
30.69 |
Zentalis Pharmaceuticals
(ZNTL)
|
0.6 |
$7.6M |
|
175k |
43.39 |
Therapeutics Acquisition Cor Com Cl A
|
0.6 |
$7.6M |
|
720k |
10.51 |
Caesarstone Ord Shs
(CSTE)
|
0.6 |
$7.3M |
|
535k |
13.73 |
Silverback Therapeutics
(SPRY)
|
0.6 |
$7.3M |
|
168k |
43.63 |
Beigene Sponsored Adr
|
0.6 |
$7.3M |
|
21k |
348.09 |
Bcls Acquisition Corp Com Cl A
|
0.6 |
$7.3M |
|
688k |
10.57 |
Trillium Therapeutics Com New
|
0.6 |
$7.2M |
|
671k |
10.74 |
Varonis Sys
(VRNS)
|
0.5 |
$7.1M |
|
139k |
51.34 |
Cyberark Software SHS
(CYBR)
|
0.5 |
$7.1M |
|
55k |
129.35 |
Dyne Therapeutics
(DYN)
|
0.5 |
$7.0M |
|
450k |
15.53 |
Allot SHS
(ALLT)
|
0.5 |
$6.7M |
|
420k |
15.97 |
Sutro Biopharma
(STRO)
|
0.5 |
$6.7M |
|
295k |
22.76 |
Verona Pharma Sponsored Ads
(VRNA)
|
0.5 |
$6.7M |
|
801k |
8.36 |
Cogent Biosciences
(COGT)
|
0.5 |
$6.7M |
|
763k |
8.78 |
Nurix Therapeutics
(NRIX)
|
0.5 |
$6.7M |
|
215k |
31.09 |
Kalvista Pharmaceuticals
(KALV)
|
0.5 |
$6.7M |
|
259k |
25.69 |
Ionis Pharmaceuticals
(IONS)
|
0.5 |
$6.5M |
|
146k |
44.96 |
Research Alliance Corp Ii Com Cl A
|
0.5 |
$6.2M |
|
600k |
10.25 |
Stoke Therapeutics
(STOK)
|
0.4 |
$5.9M |
|
151k |
38.84 |
Arya Sciences Acquisition Com Cl A
|
0.4 |
$5.5M |
|
400k |
13.78 |
Baidu Spon Adr Rep A
(BIDU)
|
0.4 |
$5.4M |
|
25k |
217.56 |
Protagonist Therapeutics
(PTGX)
|
0.4 |
$5.2M |
|
202k |
25.90 |
Arya Sciences Acqu Corp Iv Cl A
(ARYD)
|
0.4 |
$5.2M |
|
500k |
10.40 |
Mirati Therapeutics
|
0.4 |
$5.1M |
|
30k |
171.30 |
Achilles Therapeutics Sponsored Ads
(ACHL)
|
0.4 |
$5.0M |
|
300k |
16.55 |
Rada Electr Inds Com Par New
|
0.4 |
$4.9M |
|
408k |
12.01 |
Ideaya Biosciences
(IDYA)
|
0.4 |
$4.7M |
|
202k |
23.50 |
Reinvent Technology Partners Shs Cl A
|
0.4 |
$4.7M |
|
468k |
10.01 |
Celldex Therapeutics Com New
(CLDX)
|
0.3 |
$4.5M |
|
220k |
20.60 |
Mereo Biopharma Group Ads
(MREO)
|
0.3 |
$4.4M |
|
1.3M |
3.37 |
Global X Fds Put Put Option
(CLOU)
|
0.3 |
$4.4M |
|
171k |
25.74 |
Crinetics Pharmaceuticals In
(CRNX)
|
0.3 |
$4.3M |
|
284k |
15.28 |
Farfetch Ord Sh Cl A
(FTCHQ)
|
0.3 |
$4.2M |
|
80k |
53.02 |
Oric Pharmaceuticals
(ORIC)
|
0.3 |
$4.2M |
|
170k |
24.50 |
Foresight Acquisition Corp Unit 01/29/2026
|
0.3 |
$4.2M |
|
420k |
9.91 |
Shattuck Labs
(STTK)
|
0.3 |
$4.1M |
|
141k |
29.24 |
Arko Corp
(ARKO)
|
0.3 |
$4.1M |
|
408k |
9.94 |
Healthcare Capital Corp Unit 12/31/2025
|
0.3 |
$3.9M |
|
400k |
9.87 |
Inflarx Nv
(IFRX)
|
0.3 |
$3.9M |
|
1.0M |
3.90 |
Yumanity Therapeutics
|
0.3 |
$3.8M |
|
209k |
18.10 |
Catabasis Pharmaceuticals In Com New
|
0.3 |
$3.7M |
|
1.3M |
2.89 |
Cyclacel Pharmaceuticals
|
0.3 |
$3.6M |
|
508k |
7.11 |
Nkarta
(NKTX)
|
0.3 |
$3.3M |
|
101k |
32.90 |
Gracell Biotechnologies Sponsored Ads
|
0.3 |
$3.3M |
|
213k |
15.40 |
Edgewise Therapeutics
(EWTX)
|
0.2 |
$3.3M |
|
100k |
32.50 |
Lava Therapeutics Nv SHS
(LVTX)
|
0.2 |
$3.2M |
|
214k |
15.19 |
Highcape Cap Acquisition Cor Com Cl A
|
0.2 |
$3.1M |
|
257k |
11.92 |
Longview Acquisition Corp Ii Unit 99/99/9999
|
0.2 |
$3.0M |
|
300k |
10.04 |
Eucrates Biomedical Acqu Cor SHS
|
0.2 |
$3.0M |
|
304k |
9.89 |
Clarim Acquisition Corp Unit 99/99/9999
|
0.2 |
$3.0M |
|
300k |
9.95 |
Galera Therapeutics
(GRTX)
|
0.2 |
$2.9M |
|
323k |
8.82 |
Galecto
|
0.2 |
$2.7M |
|
448k |
6.08 |
I Mab Sponsored Ads
(IMAB)
|
0.2 |
$2.7M |
|
55k |
48.47 |
Phasebio Pharmaceuticals
|
0.2 |
$2.6M |
|
750k |
3.46 |
Argenx Se Sponsored Adr
(ARGX)
|
0.2 |
$2.5M |
|
9.2k |
275.38 |
Immunovant
(IMVT)
|
0.2 |
$2.5M |
|
159k |
16.04 |
Lifesci Acquisition Ii Corp
|
0.2 |
$2.5M |
|
244k |
10.14 |
Finch Therapeutics
|
0.2 |
$2.4M |
|
150k |
15.91 |
Camtek Ord
(CAMT)
|
0.2 |
$2.4M |
|
80k |
29.89 |
Instil Bio
|
0.2 |
$2.4M |
|
95k |
25.08 |
Inhibrx
|
0.2 |
$2.3M |
|
115k |
20.07 |
Turmeric Acquisition Corp Cl A
|
0.2 |
$2.1M |
|
219k |
9.77 |
Alpine Immune Sciences
|
0.2 |
$2.1M |
|
198k |
10.60 |
Foley Trasimene Acquistn Cor Com Cl A
|
0.2 |
$2.0M |
|
200k |
10.04 |
Healthcor Catalio Acqu Corp Cl A Shs
|
0.2 |
$2.0M |
|
200k |
10.00 |
Jiya Acquisition Corp Com Cl A
|
0.2 |
$2.0M |
|
199k |
9.84 |
Biogen Idec
(BIIB)
|
0.1 |
$1.9M |
|
6.8k |
279.71 |
Equillium
(EQ)
|
0.1 |
$1.8M |
|
254k |
7.15 |
Vincerx Pharma Com New
(VINC)
|
0.1 |
$1.8M |
|
94k |
19.30 |
Gigcapital4 Unit 99/99/9999
|
0.1 |
$1.7M |
|
175k |
9.87 |
Starboard Value Acquisitn Com Cl A
|
0.1 |
$1.7M |
|
171k |
9.93 |
Pieris Pharmaceuticals
|
0.1 |
$1.7M |
|
650k |
2.57 |
Dfp Healthcare Acquisitns Com Cl A
|
0.1 |
$1.6M |
|
163k |
9.96 |
Merus N V
(MRUS)
|
0.1 |
$1.6M |
|
77k |
20.89 |
Wix SHS
(WIX)
|
0.1 |
$1.6M |
|
5.7k |
279.30 |
Chinook Therapeutics
|
0.1 |
$1.6M |
|
102k |
15.54 |
Northern Star Invstmnt Corp Com Class A
(NSTB)
|
0.1 |
$1.6M |
|
155k |
10.00 |
Terns Pharmaceuticals
(TERN)
|
0.1 |
$1.5M |
|
70k |
22.00 |
Immunocore Hldgs Ads
(IMCR)
|
0.1 |
$1.5M |
|
36k |
42.58 |
Apollo Strategic Growth Capt Shs Cl A
|
0.1 |
$1.5M |
|
150k |
9.90 |
Forum Merger Iv Corp Unit 03/15/2028
|
0.1 |
$1.5M |
|
150k |
9.90 |
Landcadia Holdings Iv Unit 05/01/2025
|
0.1 |
$1.5M |
|
150k |
9.90 |
Tailwind Internatnal Acq Cor Unit 99/99/9999
|
0.1 |
$1.5M |
|
150k |
9.89 |
Alkuri Global Acquisition Unit 01/01/2028
|
0.1 |
$1.5M |
|
150k |
9.88 |
Bridgebio Pharma
(BBIO)
|
0.1 |
$1.5M |
|
24k |
61.62 |
Larimar Therapeutics
(LRMR)
|
0.1 |
$1.5M |
|
100k |
14.61 |
Gamida Cell SHS
|
0.1 |
$1.4M |
|
179k |
8.09 |
Pmv Pharmaceuticals
(PMVP)
|
0.1 |
$1.4M |
|
43k |
32.89 |
Frazier Lifesciences Acqu Cl A Shs
|
0.1 |
$1.3M |
|
127k |
9.95 |
Vertex Pharmaceuticals Incorporated
(VRTX)
|
0.1 |
$1.2M |
|
5.5k |
214.83 |
Lefteris Acquisition Corp Com Cl A
|
0.1 |
$1.2M |
|
120k |
9.84 |
Health Sciences Acq Corp 2 Ord Shs
|
0.1 |
$1.1M |
|
100k |
11.23 |
Revolution Accelertn Acqu Com Cl A
|
0.1 |
$1.1M |
|
110k |
10.14 |
Switchback Ii Corporation Com Cl A
|
0.1 |
$1.0M |
|
104k |
9.83 |
Falcon Capital Acquisitn Cor Com Cl A
|
0.1 |
$997k |
|
100k |
9.97 |
Mcap Acquisition Corp Unit 02/18/2030
|
0.1 |
$995k |
|
100k |
9.95 |
Omega Alpha Spac Cl A
|
0.1 |
$990k |
|
100k |
9.90 |
Vpc Impact Acqu Holdi Iii In Unit 99/99/9999
|
0.1 |
$987k |
|
100k |
9.87 |
Vpc Impact Acquisition Hldg Unit 03/05/2026
|
0.1 |
$986k |
|
100k |
9.86 |
890 5th Ave Partners Unit 01/12/2026
|
0.1 |
$983k |
|
99k |
9.95 |
Lionheart Acquisition Corp I Com Cl A
|
0.1 |
$982k |
|
100k |
9.82 |
E Merge Technology Acquisiti Com Cl A
|
0.1 |
$975k |
|
100k |
9.75 |
Connect Biopharma Hldgs Ads
(CNTB)
|
0.1 |
$925k |
|
50k |
18.50 |
Glass Houses Acquisition Cor Unit 03/25/2028
|
0.1 |
$902k |
|
90k |
10.04 |
NOVA MEASURING Instruments L
(NVMI)
|
0.1 |
$779k |
|
8.6k |
91.05 |
Live Oak Mobility Acquisi Unit 03/01/2028
|
0.1 |
$749k |
|
75k |
9.99 |
Cerevel Therapeutics Hldng I *w Exp 06/09/202
(CEREW)
|
0.1 |
$702k |
|
166k |
4.22 |
Landos Biopharma
|
0.1 |
$674k |
|
70k |
9.63 |
Nice Sys Note 1.250% 1/1
|
0.1 |
$666k |
|
250k |
2.66 |
Spartan Acquisition Cl A Ord
|
0.0 |
$523k |
|
50k |
10.46 |
Vectoiq Acquisition Corp Ii Unit 99/99/9999
|
0.0 |
$507k |
|
50k |
10.14 |
Stratim Cloud Acquisition Unit 03/05/2026
|
0.0 |
$500k |
|
50k |
10.00 |
Z-work Acquisition Corp Unit 99/99/9999
|
0.0 |
$498k |
|
50k |
9.96 |
Ejf Acquisition Corp Unit 03/10/2026
|
0.0 |
$497k |
|
50k |
9.96 |
Agile Growth Corp Unit 03/09/2026
|
0.0 |
$496k |
|
50k |
9.92 |
Mdh Acquisition Corp Unit 99/99/9999
|
0.0 |
$308k |
|
31k |
9.94 |
Cm Life Sciences Com Cl A
|
0.0 |
$298k |
|
20k |
14.90 |
Immatics *w Exp 07/01/202
(IMTXW)
|
0.0 |
$295k |
|
100k |
2.95 |
Noble Rock Acquisition Corp Unit 01/31/2028
|
0.0 |
$277k |
|
28k |
9.89 |
Fintech Evolution Acquis Gro Unit 99/99/9999
|
0.0 |
$247k |
|
25k |
9.88 |
Sarissa Capital Acquisitn Cl A
|
0.0 |
$242k |
|
24k |
10.13 |
Neubase Therapeutics Ord
|
0.0 |
$236k |
|
32k |
7.40 |
Outlook Therapeutics *w Exp 02/18/202
|
0.0 |
$131k |
|
130k |
1.01 |